BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7357032)

  • 1. The metabolic effects of oxalate on intact red blood cells.
    Buc HA; Demaugre F; Cépanec C; Leroux JP
    Biochim Biophys Acta; 1980 Mar; 628(2):136-44. PubMed ID: 7357032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic consequences of pyruvate kinase inhibition by oxalate in intact rat hepatocytes.
    Buc HA; Demaugre F; Moncion A; Leroux JP
    Biochimie; 1981 Jul; 63(7):595-602. PubMed ID: 7284471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modelling of metabolic pathways affected by an enzyme deficiency. A mathematical model of glycolysis in normal and pyruvate-kinase-deficient red blood cells.
    Holzhütter HG; Jacobasch G; Bisdorff A
    Eur J Biochem; 1985 May; 149(1):101-11. PubMed ID: 3996397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxalate and malonate on red cell metabolism.
    Beutler E; Forman L; West C
    Blood; 1987 Nov; 70(5):1389-93. PubMed ID: 2822172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of lactate dehydrogenase in the purified state and in intact erythrocytes.
    Simpson RJ; Brindle KM; Brown FF; Campbell ID; Foxall DL
    Biochem J; 1982 Mar; 202(3):581-7. PubMed ID: 7092832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Deficiency of pyruvate kinase in erythrocytes: biochemical studies. Preliminary communication].
    Stanulović M; Jerance D; Stojimirović E
    Bilt Hematol Transfuz; 1977; 5(3-4):95-6. PubMed ID: 615616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic manipulation of key glycolytic enzymes: a novel proposal for the maintenance of red cell 2,3-DPG and ATP levels during storage.
    Vora S
    Biomed Biochim Acta; 1987; 46(2-3):S285-9. PubMed ID: 3593307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular free magnesium and phosphorylated metabolites in hexokinase- and pyruvate kinase-deficient red cells measured using 31P-NMR spectroscopy.
    Ouwerkerk R; van Echteld CJ; Staal GE; Rijksen G
    Biochim Biophys Acta; 1989 Mar; 1010(3):294-303. PubMed ID: 2920177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glycolytic enzyme activity and levels of glycolysis metabolites in erythrocytes in physiological pregnancy].
    D'iakova NG; Chernyshov VG
    Vopr Med Khim; 1985; 31(2):17-20. PubMed ID: 4002652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of human erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases. Comparison with human liver L-type enzyme.
    Marie J; Buc H; Simon MP; Kahn A
    Eur J Biochem; 1980; 108(1):251-60. PubMed ID: 6250830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic regulation of Rana balcanica erythrocyte pyruvate kinase.
    Kaloyianni M; Cotoglou C; Giagtzoglou N
    J Comp Physiol B; 2000 Mar; 170(2):85-90. PubMed ID: 10791568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate kinase and the "high ATP syndrome".
    Staal GE; Jansen G; Roos D
    J Clin Invest; 1984 Jul; 74(1):231-5. PubMed ID: 6736249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of erythrocyte pyruvate kinase deficiency and normal values of enzyme in a Turkish population.
    Akin H; Baykal-Erkiliç A; Aksu A; Yücel G; Gümüşlü S
    Hum Hered; 1997; 47(1):42-6. PubMed ID: 9017979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical and laboratory characteristics of congenital pyruvate kinase deficiency].
    Song L; Li Y; Peng GX; Zhang L; Jing LP; Zhou K; Li Y; Ye L; Li JP; Fan HH; Zhao X; Yang WR; Yang Y; Zhao YP; Xiong YZ; Wu ZJ; Zhang FK
    Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):511-513. PubMed ID: 29996270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinetic effects of oxalate on liver and erythrocyte pyruvate kinases.
    Buc H; Demaugre F; Leroux JP
    Biochem Biophys Res Commun; 1978 Nov; 85(2):774-9. PubMed ID: 736935
    [No Abstract]   [Full Text] [Related]  

  • 17. A monomeric form of pyruvate kinase in human pyruvate kinase deficiency.
    Adachi K; Ghory PK; Asakura T; Schwartz E
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):501-4. PubMed ID: 15247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolysis in human erythrocytes containing elevated concentrations of 2, 3-P2-glycerate.
    Duhm J
    Biochim Biophys Acta; 1975 Mar; 385(1):68-80. PubMed ID: 236004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Control of glycolysis in magnesium deficiency: studies on intact red cells and hemolysates].
    Jacobasch G; Gerth C; Fabricius PG
    Acta Biol Med Ger; 1977; 36(3-4):587-96. PubMed ID: 145777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-dependent phosphorylation of erythrocyte variant pyruvate kinase.
    Fujii S; Nakashima K; Yanagihara T; Shinohara K; Kaneko T
    Biochem Med; 1984 Feb; 31(1):47-53. PubMed ID: 6331423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.